NIAID director Dr. Anthony Fauci, a financial ally of Bill Gates whose institute is part of NIH, has been critical of Hydroxychloroquine and the FBI even raided a health spa serving intravenous vitamin C, which are competitors to a vaccine. (RELATED: Eight NIH Coronavirus Panel Experts Disclose Financial Relationships With Price-Hiking Drugmaker Gilead).
"We do have some particular stake in the intellectual property" for the Moderna vaccine stated Francis Collins, the director of NIH, in a revelatory recent Economic Club panel discussion. "One of the vaccines– the one that's furthest along– what started, actually, at the federal government in our own Vaccine Research Center at NIH– then worked with a biotechnology company called Moderna to get to where we are now, with very impressive Phase I results and getting ready to go into a large-scale trial as early as July. That one, of course, we do have some particular stake in the intellectual property. Others, though, come from companies who've invested their efforts into getting them to the point where they might now be ready for a trial," Collins stated.
Newly published documents from Public Citizen have massive implications. Public Citizen states:
"The U.S. government may jointly own a potential coronavirus vaccine. The National Institutes of Health (NIH) has played a critical role in coronavirus research for years. Building off this work, federal scientists have helped design and test mRNA-1273—a vaccine candidate developed in partnership with Moderna. The federal government has filed multiple patents covering mRNA-1273. In this report, we describe two patent applications that list federal scientists as co-inventors. If the government successfully pursued its patent filings, the resulting patents would likely confer significant rights. We also review recently disclosed contracts between NIH and Moderna. The agreements suggest that NIH has not transferred its rights, but instead maintains a joint stake."